Enjoy complimentary customisation on priority with our Enterprise License!
The microrna (mirna) market size is forecast to increase by USD 3.19 billion at a CAGR of 23.31% between 2023 and 2028.
The microrna (mirna) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The miRNA market encompasses a range of applications, including cancer, cardiovascular diseases, neurological disorders, and infectious diseases. This market is driven by the increasing demand for genomic technologies, precision medicine, and noninvasive biomarkers. MiRNAs play a crucial role in gene regulation, disease diagnostics, and therapeutic applications. They are used for target prediction, vaccine development, and immunological status assessment. The market includes research institutions and academic institutes, which contribute significantly to the advancement of miRNA-based therapeutics and diagnostics. Consumables, such as whole blood, serum, and plasma, are essential for miRNA isolation and purification, and their repeated usage fuels market growth. End-users, including healthcare facilities and clinical trials, require a variety of reagents and kits for miRNA detection and analysis.
The market also includes instruments, diagnostic kits, real-time PCR, next-generation sequencing, microarrays, and liquid biopsies. Standardized protocols and high-quality samples are crucial for accurate and reliable miRNA analysis. The market is poised for growth due to the potential of miRNAs in early detection and treatment of chronic disorders, tumor suppressor miRNAs, and therapeutic compounds.
Get a glance at the Microrna (Mirna) Industry report of share of various segments Request Free Sample
The Consumables segment was valued at USD 484.70 billion in 2018 and showed a gradual increase during the forecast period.
Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions, Request Free Sample
The miRNA market in North America is currently the largest globally, driven by substantial investment in gene therapy research, particularly In the US. With over 500 ongoing clinical trials In the region, primarily focusing on cancer, HIV/AIDS, and cardiovascular diseases, miRNA holds significant potential for therapeutic advancements. Cancer remains a major health concern in North America, accounting for a significant number of new cases each year, according to the Centers for Disease Control and Prevention (CDC). MiRNAs play a crucial role in gene regulation, biomarker discovery, and therapeutic applications, including cancer treatment, immunological status monitoring, and vaccine development. Key areas of research include RNA profiling, gene regulatory networks, and molecular diagnostics, utilizing technologies such as real-time PCR, next-generation sequencing, microarrays, and liquid biopsies.
The region's healthcare facilities and research institutions are at the forefront of developing high-quality samples, standardized protocols, and therapeutic compounds, contributing to the growth of the miRNA market.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Increasing prevalence of neurological disorders is the key driver of the market.
Increasing number of partnerships and collaborations of market vendors is the upcoming market trend.
What challenges does the Microrna (Mirna) Industry face during its growth?
High heterogeneity of methodologies associated with miRNA is a key challenge affecting the industry growth.
Exclusive Customer Landscape
The microrna (mirna) market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the microrna (mirna) market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, microrna (mirna) market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.
BioGenex Laboratories Inc. - The company specializes in providing microRNA (miRNA) analysis solutions, utilizing advanced techniques such as Reverse Transcription Quantitative Polymerase Chain Reaction (RT-qPCR) for the sensitive detection and quantification of miRNA molecules. This technology enables researchers to gain insights into miRNA expression profiles, contributing to a deeper understanding of various biological processes and potential therapeutic applications.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market encompasses a broad spectrum of applications, including diagnostics and therapeutics, in various disease areas such as cancer, cardiovascular diseases, neurological disorders, and infectious diseases. MiRNAs are small non-coding RNAs that play a crucial role in gene regulation, immunological status, and cellular processes. Their therapeutic potential lies In their ability to modulate gene expression, making them attractive candidates for the development of novel therapeutic strategies. MiRNAs have gained significant attention in recent years due to their potential applications in precision medicine. The use of miRNAs as noninvasive biomarkers for disease diagnostics has shown promise in various fields, including molecular diagnostics and translational medicine.
For instance, miRNAs have been identified as potential biomarkers for acute kidney injury, cancer, and infectious diseases. The development of miRNA-based therapeutics is another promising area of research. MiRNAs have been shown to act as tumor suppressors and oncogenes, making them potential targets for cancer treatment. Additionally, miRNAs have been explored for their potential in gene regulatory networks and RNA biology, offering new therapeutic options for chronic disorders. The miRNA market is driven by several factors, including the increasing demand for early detection and precision medicine, advancements in gene regulation and RNA biology, and the growing number of clinical studies and clinical trials.
Furthermore, the availability of research tools such as real-time PCR, next-generation sequencing, microarrays, and liquid biopsies has facilitated the isolation and purification of miRNAs, enabling their use in various applications. The market for miRNA diagnostics and therapeutics is expected to grow significantly In the coming years, driven by the increasing demand for high-quality samples and standardized protocols. The use of miRNAs in research institutions, academic institutes, and healthcare facilities is also expected to increase, as the potential applications of miRNAs continue to be explored. The development of miRNA-based therapeutics is still in its infancy, and significant challenges remain, including the identification of specific miRNAs for various diseases, the development of efficient delivery systems, and the optimization of manufacturing processes.
However, the potential benefits of miRNA-based therapies are significant, and ongoing research is expected to yield new therapeutic compounds and diagnostic kits. In conclusion, the miRNA market is a dynamic and rapidly evolving field, driven by the increasing demand for early detection and precision medicine, advancements in gene regulation and RNA biology, and the growing number of clinical studies and clinical trials. The potential applications of miRNAs in diagnostics and therapeutics are vast, and ongoing research is expected to yield new discoveries and innovations in this exciting field.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
166 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 23.31% |
|
Market growth 2024-2028 |
USD 3186.2 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
18.59 |
|
Key countries |
US, Germany, UK, Canada, and China |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this microrna (mirna) market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
